Medical writer

Acquired during education, training, work experience and extra-curricular activities (theatre workshops):
• Science dissemination and communication;
• Critical thinking;
• Analytical mindset;
• Problem solving;
• Ability to work under pressure;
• Willingness to learn;
• Team spirit;
• Sense of responsibility and organizational skills;
• Communication, social and creative skills (acquired during theatre workshops).

1.	C. Casalou*, A. Faustino*, F. Silva, I. C. Ferreira, D. Vaqueirinho, A. Ferreira, P. Castanheira, T. Barona, J. S. Ramalho, J. Serpa*, A. Félix*, D. C. Barral, Arl13b regulates breast cancer cell migration and invasion by controlling integrin-mediated signalling, Cancers (Basel). (2019) 11(10): 1461.
*These authors contributed equally to this work.
2.	C. Casalou, A. Faustino, D. C. Barral, Arf proteins in cancer cell migration, Small GTPases. (2016) 7(4):270-282.
3.	O. S. Rathore, A. Faustino, P. Prudencio, P. Van Damme, C. J. Cox, R. G. Martinho, Absence of N-terminal acetyltransferase diversification during evolution of eukaryotic organisms, Sci Rep. (2016) 6, 21304.
4.	H. Pópulo, S. Tavares, A. Faustino, J. B. Nunes, J. M. Lopes., P. Soares, GNAQ and BRAF mutations show differential activation of the mTOR pathway in human transformed cells, PeerJ. (2013) 1:e104 . 
5.	R. Celestino, J. Lima, A. Faustino, J. Vinagre, V. Máximo, A. Gouveia, P. Soares, J. M. Lopes, Molecular alterations and expression of succinate dehydrogenase (SDH) complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors, Eur J Hum Genet. (2013) 21(5): 503-10. 
6.	A. Faustino*, J. P. Couto*, H. Pópulo, A.S. Rocha, F. Pardal, J. M. Cameselle-Teijeiro, J. M. Lopes, M. Sobrinho-Simões, P. Soares, mTOR Pathway Overactivation in BRAF Mutated Papillary Thyroid Carcinoma, J Clin Endocrinol Metab. (2012) 97(7): E1139-E1149. 
*These authors contributed equally to this work.
7.	R. Celestino, J. Lima, A. Faustino, V. Máximo, A. Gouveia, J. Vinagre, P. Soares, J. M. Lopes, A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney-Stratakis dyad, Fam Cancer. (2012) 11(2):189-94.
8.	H. Pópulo, P. Soares, A. Faustino, A.S. Rocha, P. Silva, F. Azevedo, J. M. Lopes, mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics, Pigment Cell Melanoma Res. (2011) 24(1):254-7.
9.	H. Faneca, A. Faustino, M.C. Pedroso de Lima, Synergistic antitumoral effect of vinblastine and HSV-Tk/GCV gene therapy mediated by albumin-associated cationic liposomes, J Control Release. (2008) 126(2):175-84. 

Oral communications:
1.	A. Faustino, C. Casalou, D.C. Barral (2018) A new role for Arl13b in cancer cell migration and invasion through the regulation of cell adhesion. 2nd NMS Symposium on Chronic Diseases and Translational Science 2018, 18-19 October, Lisbon, Portugal.
2.	A. Faustino, C. Casalou, D.C. Barral (2018) A new role for Arl13b in cancer cell migration and invasion through the regulation of cell adhesion. SINAL 2018 - 9th Meeting on Signal Transduction, 20-21 September, Lisbon, Portugal.
3.	A. Faustino, C. Casalou, D.C. Barral (2018) A new role for Arl13b in cancer cell migration and invasion through the regulation of cell adhesion. 7th French Cell Adhesion Club Symposium, 23-25 May, Strasbourg, France.

Posters:
1.	A. Faustino, C. Casalou, D. C. Barral (2017) A new role for Arl13b in the regulation of cell-cell and cell-extracellular matrix adhesion. SINAL 2017 - 8th Meeting on Signal Transduction, 1-2 June, Lisbon, Portugal.
2.	A. Faustino, C. Casalou, J. Serpa, D. C. Barral (2016) A new role for Arl13b in cancer cell migration and invasion. EMBO Young Scientists' Forum 2016 (EYSF2016), 1-2 September, Lisbon, Portugal.
3.	H. Pópulo, A. Faustino, S. Tavares, J. B. Nunes, J. M. Lopes, P. Soares (2012). Differential activation of the mTOR pathway in BRAF and GNAQ human transformed cells. XXI Porto Cancer Meeting: Metabolism and Cancer: from etiopathogenesis to therapy, 19-20 April, Porto, Portugal.
4.	H. Pópulo, A. Faustino, S. Tavares, J. M. Lopes, P. Soares (2011). Evaluation of melanoma cell lines sensitivity to RAD001 treatment. XX Porto Cancer Meeting: Drug Resistance in Cancer: from biology to molecular targets and drugs, 28-29 April, Porto, Portugal.
5.	A. Faustino, A. S. Rocha, H. Pópulo, P. Soares, M. Sobrinho-Simões (2009). Overactivation of the PI3K/AKT/mTOR pathway is observed in thyroid benign diseases. 34th Annual Meeting of the European Thyroid Association (ETA), 5-9 September, Lisbon, Portugal.
6.	A. Faustino, A. S. Rocha, H. Pópulo, P. Soares (2008). What can we learn from animal models that can be useful in human thyroid pathology? Centro de Investigaciones Oncológicas (CNIO) Cancer Conference: "SIGNALLING UPSTREAM OF mTOR"/Program, 3–5 November, Madrid, Spain.